An as-yet limited body of evidence suggests that calcium-regulating endocrine hormones - in particular, parathyroid hormone-related peptide (PTHrP) - may have unappreciated cardioprotective effects. The current review focuses on the concept that PTHrP may, via modulation of classic cardioprotective signaling pathways, provide a novel strategy to attenuate myocardial ischemia-reperfusion injury.
|Number of pages||9|
|Journal||Journal of Cardiovascular Pharmacology and Therapeutics|
|State||Published - Nov 1 2017|
- mitogen-activated protein kinase phosphatase 1
- parathyroid hormone-related peptide